Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Good

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Advanced Healthcare Materials|October 30, 2021
Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective ImmunityShuxiong Chen, Benjamin Evert, Adetayo Adeniyi, et al.
The American Journal of Pathology|June 30, 2007
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malariaFiona H Amante, Amanda C Stanley, Louise M Randall, et al.
Journal of Medicinal Chemistry|December 10, 2014
Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccineTzu-Yu Liu, Waleed M Hussein, Ashwini Kumar Giddam, et al.
Science Advances|September 14, 2019
Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized miceManisha Pandey, Ainslie Calcutt, Victoria Ozberk, et al.
Malaria Journal|June 9, 2009
Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malariaTonia Woodberry, Alberto Pinzon-Charry, Kim A Piera, et al.
Infection and Immunity|October 17, 2018
Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria ParasitesLeanne M Low, Aloysious Ssemaganda, Xue Q Liu, et al.
Metallomics : Integrated Biometal Science|February 22, 2018
Gold(i) phosphine compounds as parasite attenuating agents for malaria vaccine and drug developmentAloysious Ssemaganda, Leanne M Low, Krista R Verhoeft, et al.
Scientific Reports|December 16, 2016
Novel platform technology for modular mucosal vaccine that protects against streptococcusMehfuz Zaman, Victoria Ozberk, Emma L Langshaw, et al.
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Nature Communications|September 25, 2023
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophilsVictoria Ozberk, Mehfuz Zaman, Ailin Lepletier, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Advanced Healthcare Materials|October 30, 2021
Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective ImmunityShuxiong Chen, Benjamin Evert, Adetayo Adeniyi, et al.
The American Journal of Pathology|June 30, 2007
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malariaFiona H Amante, Amanda C Stanley, Louise M Randall, et al.
Journal of Medicinal Chemistry|December 10, 2014
Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccineTzu-Yu Liu, Waleed M Hussein, Ashwini Kumar Giddam, et al.
Science Advances|September 14, 2019
Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized miceManisha Pandey, Ainslie Calcutt, Victoria Ozberk, et al.
Malaria Journal|June 9, 2009
Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malariaTonia Woodberry, Alberto Pinzon-Charry, Kim A Piera, et al.
Infection and Immunity|October 17, 2018
Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria ParasitesLeanne M Low, Aloysious Ssemaganda, Xue Q Liu, et al.
Metallomics : Integrated Biometal Science|February 22, 2018
Gold(i) phosphine compounds as parasite attenuating agents for malaria vaccine and drug developmentAloysious Ssemaganda, Leanne M Low, Krista R Verhoeft, et al.
Scientific Reports|December 16, 2016
Novel platform technology for modular mucosal vaccine that protects against streptococcusMehfuz Zaman, Victoria Ozberk, Emma L Langshaw, et al.
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Nature Communications|September 25, 2023
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophilsVictoria Ozberk, Mehfuz Zaman, Ailin Lepletier, et al.
Pageof 22